CLS is committed to providing the media with timely and accurate information related to California’s life sciences ecosystem. CLS welcomes all media inquiries from news organizations and reporters. Members of the media interested in speaking with CLS opinion leaders on issues of public policy, life sciences innovation, or issues related to the life sciences ecosystem in California, please contact our communication department.
Media Contact: [email protected]
AB 1887 Signed Into Law
Sep 28, 2026
Governor Gavin Newsom has signed AB 1887 into law — a critical step forward for California's rare disease community. This legislation eliminates prior authorization and step therapy delays for FDA-approved rare disease treatments, ensuring patients can access the care their doctors prescribe without unnecessary insurance red tape.
Read MoreCalifornia Life Sciences Announces Fall 2026 FAST California Cohort
Sep 11, 2026
California Life Sciences (CLS) today announced that 11 companies have been accepted into the Fall 2026 cohort of FAST California, the association’s flagship innovation and entrepreneurship program.
Read MoreCalifornia Life Sciences (CLS) Elects New Board Chair, Vice Chair, and Four Members to Board of Directors
Sep 8, 2026
California Life Sciences (CLS) today announced new leadership and four new members for its Board of Directors.
Read MoreA treatment in search of a disease – Legislation unnecessarily threatens California’s leadership in life sciences
Jul 27, 2026
The success and productivity of California’s life sciences ecosystem rely on its unique, interconnected structure.
Read MoreAt BIO 2026, industry wrestled with Washington politics, and making AI work better
Jun 25, 2026
Executives talked about strategies to adapt to Trump’s way of governance, and the rising cost of AI
Read MoreCalifornia Life Sciences’ Statement on HHS Clinical Trial Effort
Jun 23, 2026
Read CLS President & CEO Mike Guerra's statement on the Department of Health and Human Services' coordinated effort to restore U.S. leadership in clinical trials.
Read More